AVA Stock Analysis: Avista | NYSE
Utilities - Diversified | NYSE, USA | Market Cap: 3.360m USD | 12M Return: 14.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 31.7M
EPS Trend: 54.4%
Qual. Beats: 0
Rev. Trend: 84.1%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Avista Corporation is a U.S. electric and natural gas utility operating through two segments: Avista Utilities, which distributes electricity and natural gas across parts of eastern Washington, northern Idaho, and Oregon, and Alaska Electric Light and Power (AEL&P), which serves Juneau, Alaska. The company generates electricity from a mix of hydroelectric, thermal, wind, and solar facilities, and as of December 31, 2025, it served roughly 429,000 retail electric customers, 386,000 retail natural gas customers, and 17,600 electrical energy customers. Beyond its core utility operations, Avista also holds venture fund, real estate, and other investments, and it is headquartered in Spokane, Washington, having been originally incorporated in 1889 and previously known as Washington Water Power.
As a multi-utility operator in the regulated Utilities sector, Avistas earnings are largely driven by rate-regulated returns on its transmission and distribution infrastructure, with revenues determined through state-level regulatory proceedings in Washington, Idaho, Oregon, and Alaska. Its business model is capital-intensive and characterized by long-lived generation and grid assets, including the hydroelectric and diesel capacity that supplies the Juneau service area.
- Washington and Idaho rate case rulings determine allowed return
- Hydroelectric generation output swings with regional precipitation and snowpack
- Rising interest costs pressure financing on multi-billion capital expenditure plans
| Net Income: 206.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -1.95 > 1.0 |
| NWC/Revenue: -4.43% < 20% (prev -2.78%; Δ -1.66% < -1%) |
| CFO/TA 0.06 > 3% & CFO 464.0m > Net Income 206.0m |
| Net Debt (3.36b) to EBITDA (665.0m): 5.05 < 3 |
| Current Ratio: 0.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (82.4m) vs 12m ago 2.55% < -2% |
| Gross Margin: 56.08% > 18% (prev 60.91%; Δ -4.83% > 0.5%) |
| Asset Turnover: 23.42% > 50% (prev 24.42%; Δ -1.01% > 0%) |
| Interest Coverage Ratio: 2.55 > 6 (EBIT TTM 380.0m / Interest Expense TTM 149.0m) |
| A: -0.01 (Total Current Assets 735.0m - Total Current Liabilities 820.0m) / Total Assets 8.41b |
| B: 0.11 (Retained Earnings 956.0m / Total Assets 8.41b) |
| C: 0.05 (EBIT TTM 380.0m / Avg Total Assets 8.19b) |
| D: 0.49 (Book Value of Equity 2.78b / Total Liabilities 5.63b) |
| Altman-Z'' = 1.13 = BB |
| DSRI: 0.90 (Receivables 227.0m/257.0m, Revenue 1.92b/1.95b) |
| GMI: 1.09 (GM 60.91% / 56.08%) |
| AQI: 0.97 (AQ_t 0.14 / AQ_t-1 0.14) |
| SGI: 0.99 (Revenue 1.92b / 1.95b) |
| TATA: -0.03 (NI 206.0m - CFO 464.0m) / TA 8.41b) |
| Beneish M = -3.06 (Cap -4..+1) = AA |
As of July 12, 2026, the stock is trading at USD 41.90 with a total of 420,735 shares traded. Over the past week, the price has changed by +1.21%, over one month by -1.16%, over three months by +1.28% and over the past year by +14.92%.
Current recommended Stop Loss: 40.60 (which is 3.1% or 1.5 ATR below the current price).
Avista has received a consensus analysts rating of 3.20. Therefore, it is recommended to hold AVA.
- StrongBuy: 1
- Buy: 0
- Hold: 3
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 41.7 | -0.5% |
P/E Trailing = 16.1992
P/E Forward = 15.748
P/S = 1.7528
P/B = 1.2324
P/EG = 2.6236
Revenue TTM = 1.92b USD
EBIT TTM = 380.0m USD
EBITDA TTM = 665.0m USD
Long Term Debt = 2.81b USD (from longTermDebt, last quarter)
Short Term Debt = 385.0m USD (from shortTermDebt, last quarter)
Debt = 3.38b USD (from shortLongTermDebtTotal, last quarter) + Leases 92.0m
Net Debt = 3.36b USD (calculated: Debt 3.38b - CCE 18.0m)
Enterprise Value = 6.72b USD (3.36b + Debt 3.38b - CCE 18.0m)
Interest Coverage Ratio = 2.55 (Ebit TTM 380.0m / Interest Expense TTM 149.0m)
EV/FCF = -43.90x (Enterprise Value 6.72b / FCF TTM -153.0m)
FCF Yield = -2.28% (FCF TTM -153.0m / Enterprise Value 6.72b)
FCF Margin = -7.98% (FCF TTM -153.0m / Revenue TTM 1.92b)
Net Margin = 10.75% (Net Income TTM 206.0m / Revenue TTM 1.92b)
Gross Margin = 56.08% ((Revenue TTM 1.92b - Cost of Revenue TTM 842.0m) / Revenue TTM)
Gross Margin QoQ = 63.86% (prev 26.64%)
Tobins Q-Ratio = 0.80 (Enterprise Value 6.72b / Total Assets 8.41b)
Interest Expense / Debt = 4.41% (Interest Expense 149.0m / Debt 3.38b)
Taxrate = 10.82% (25.0m / 231.0m)
NOPAT = 338.9m (EBIT 380.0m * (1 - 10.82%))
Current Ratio = 0.90 (Total Current Assets 735.0m / Total Current Liabilities 820.0m)
Debt / Equity = 1.22 (Debt 3.38b / totalStockholderEquity, last quarter 2.78b)
Debt / EBITDA = 5.05 (Net Debt 3.36b / EBITDA 665.0m)
Debt / FCF = -21.94 (negative FCF - burning cash) (Net Debt 3.36b / FCF TTM -153.0m)
Total Stockholder Equity = 2.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.52% (Net Income 206.0m / Total Assets 8.41b)
RoE = 7.65% (Net Income TTM 206.0m / Total Stockholder Equity 2.69b)
RoCE = 6.91% (EBIT 380.0m / Capital Employed (Equity 2.69b + L.T.Debt 2.81b))
RoIC = 4.26% (NOPAT 338.9m / Invested Capital 7.96b)
WACC = 4.63% (E(3.36b)/V(6.74b) * Re(5.33%) + D(3.38b)/V(6.74b) * Rd(4.41%) * (1-Tc(0.11)))
Discount Rate = 5.33% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 100.00 | Cagr: 2.40%
[DCF] Fair Price = unknown (Cash Flow -153.0m)
EPS Correlation: 54.40 | EPS CAGR: 4.61% | SUE: 0.80 | # QB: 0
Revenue Correlation: 84.10 | Revenue CAGR: 4.69% | SUE: -1.31 | # QB: -1
EPS current Quarter (2026-06-30): EPS=0.25 | Chg30d=-4.47% | Revisions=-25% | Analysts=6
EPS next Quarter (2026-09-30): EPS=0.36 | Chg30d=-3.12% | Revisions=-25% | Analysts=6
EPS current Year (2026-12-31): EPS=2.60 | Chg30d=-0.11% | Revisions=-25% | GrowthEPS=+9.3% | GrowthRev=+1.4%
EPS next Year (2027-12-31): EPS=2.79 | Chg30d=+0.02% | Revisions=+25% | GrowthEPS=+7.2% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: -29% (up=1, down=3)